Oramed Pharmaceuticals Stock
Price
Target price
€2.29
€2.29
2.740%
0.061
2.740%
-
10:18 / Tradegate
WKN: A1CTNU / Symbol: ORMP / Name: Oramed / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Oramed Pharmaceuticals Stock
Oramed Pharmaceuticals gained 2.740% today.
Our community identified positive and negative aspects for Oramed Pharmaceuticals stock for the coming years. 0 users see the criterium "Brand" as a plus for the Oramed Pharmaceuticals stock. On the other hand our users think that "Brand" could be a problem in the future.
Oramed is a pharmaceutical company that focuses on the development of innovative oral delivery solutions for drugs that are traditionally administered through injection. The company is primarily dedicated to the development of an oral insulin capsule that can potentially revolutionize the treatment of diabetes. Their flagship product, ORMD-0801, is currently in Phase III clinical trials in the United States and has received Fast Track designation from the FDA. Oramed is a publicly traded company listed on the Nasdaq under the ticker symbol ORMP.
Pros and Cons of Oramed Pharmaceuticals in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Oramed Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Oramed Pharmaceuticals | 2.740% | 2.065% | -16.860% | 8.382% | 5.104% | -72.475% | -34.895% |
| Enlivex Therapeutics Ltd. | 5.690% | -13.986% | -63.393% | -53.409% | -45.089% | -84.815% | - |
| Galmed Pharmaceuticals Ltd. | -1.760% | 9.524% | 27.778% | 28.671% | -15.596% | - | - |
| Salarius Pharmaceuticals Inc. | -3.170% | 2.315% | -15.000% | -67.971% | -20.360% | -98.187% | -99.994% |